🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

MD Anderson’s Institute for Data Science in Oncology announces its inaugural cohort of IDSO Affiliates. The expertise of these 33 scientists, clinicians and staff will help advance collaborative data science work and our mission to #EndCancer. bit.ly/3vpeemS Caroline Chung, MD

Attending the tournament today? Memorial Park Golf Course is smoke- and vape-free! We’re happy to do our part to help MD Anderson Cancer Center #EndCancer

This week, our researchers will share groundbreaking cancer research, including 235 abstracts, at the 2024 AACR Annual Meeting. Keep up with the latest MD Anderson research coming out of #AACR24: brnw.ch/21wIuia. #EndCancer

The next generation of KRAS inhibitors is on the horizon for treating pancreatic, colorectal and lung cancers. Read about our latest research, including presentations at #AACR24: brnw.ch/21wIyII Scott Kopetz David S. Hong MD Dr. Shubham Pant #EndCancer

We congratulate the recipient of the AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research, Scott Kopetz, MD, PhD. Dr. Kopetz will present his Award Lecture at #AACR24 on Sunday April 7, 4:30-5:15 PM. Learn more: bit.ly/49qft38

Happening now at #AACR24: Dr. Scott Kopetz, AACR Waun Ki Hong Award recipient, is giving a lecture on Adaptive Resistance in BRAF- and KRAS-mutated #ColorectalCancer. Scott Kopetz #EndCancer

The first-in-class PARP1-selective inhibitor saruparib demonstrates early efficacy and an improved safety profile in breast cancers with DNA repair defects. See the findings presented by our Dr. Timothy Yap (CT014): bit.ly/43SfsE7 AACR #AACR24 #BSCM #EndCancer

There’s still time to meet our experts today at #AACR24. See the schedule: MDAnderson.org/AACR AACR #EndCancer

"If exercise and food are medicine, how can we as a society and as health care systems get patients to take this?" says our Dr. Karen Basen-Engquist of improving health behavior practices in cancer survivors.brnw.ch/21wIFt8 AACR Karen Basen-Engquist, PhD #AACR24 #EndCancer

Thank you to everyone who stopped by our booth at #AACR24 to discuss the latest cancer research advances. We hope to see you all again next year. #EndCancer

MD Anderson and CureVac announce a strategic collaboration to develop off-the-shelf mRNA-based cancer vaccines for select hematologic and solid tumors. Read about it here: brnw.ch/21wIRth CureVac #EndCancer

Our Chief Patient Experience Officer Dr. Michael Frumovitz is committed to making sure patients, their families and staff members feel heard, valued and empowered at MD Anderson. He has been named one of the 2024 top chief experience officers to know by Becker's Hospital Review.

Reflection on an extraordinary day celebrating RUSH MD Anderson Cancer Center across the region — two stellar organizations with world-class teams working together to #EndCancer and save more lives. MD Anderson Cancer Center Rush University System for Health

Children receiving cancer treatment at MD Anderson treated to special prom party palooza Troy Kless  MD Anderson Cancer Center khou.com/article/life/h…

Congratulations to our Dr. Sharon Dent on her election to National Academy of Sciences for her contributions to chromatin research, which have furthered our understanding of cancer mutations. She joins eight previously elected researchers from MD Anderson. bit.ly/3WrKFft Peter WT Pisters, MD

Amazing leadership lessons on and off the court with tennis legends Chris Evert and Martina Navratilova. Thank you for sharing your journey with us. MD Anderson Cancer Center #endcancer

Selfless service. Loved spreading the spirit of the #12thMan, making memories with the children at MD Anderson Cancer Center and passing out gifts of iPads, 12th Man towels and hats. #EndCancer #GigEm

Our teams MD Anderson Cancer Center are grateful to the Belfer family for their forward-thinking vision and for their renewed investment in the Belfer Neurodegeneration Consortium. Their generosity has and will continue to impact countless lives. #EndCancer

“Working in the lab is really where I felt at home,” says our Dr. Kenneth Hu, a researcher studying tumor cell interactions to advance immunotherapy. Here, he shares why MD Anderson is the perfect place to do that: brnw.ch/21wKe0q #Immunology #EndCancer

Stop by #ASCO24 Booth 13069 to meet our experts and learn about training and career opportunities at MD Anderson. Find the full schedule at MDAnderson.org/ASCO. ASCO #EndCancer